Echinaforce Comp: Uses, Dosage & Side Effects
Herbal combination medicine with Echinacea purpurea and Elderberry for immune support
Quick facts about Echinaforce Comp
Key takeaways about Echinaforce Comp
- Dual-action herbal formula: Combines Echinacea purpurea (immune stimulant) with elderberry (antiviral and antioxidant properties) for synergistic cold and flu relief
- Clinically studied: Randomized controlled trials have shown that Echinacea preparations can reduce cold duration by 1–4 days and reduce symptom severity
- Not for autoimmune conditions: People with autoimmune diseases, HIV/AIDS, tuberculosis, or other progressive systemic diseases must not use this product
- Short-term use recommended: Use for up to 10 days for acute symptoms; consult a doctor if symptoms persist beyond this period
- Watch for allergic reactions: Those with known allergy to plants in the daisy family (Asteraceae) should avoid Echinaforce Comp
What Is Echinaforce Comp and What Is It Used For?
Echinaforce Comp is a herbal medicinal product containing extracts of Echinacea purpurea (purple coneflower) combined with elderberry (Sambucus nigra) concentrate. It is used to relieve symptoms and shorten the duration of common colds and flu-like infections by supporting the body's natural immune defenses.
Echinaforce Comp belongs to the category of herbal medicinal products used in phytotherapy — the practice of using plant-based preparations for therapeutic purposes. The product is manufactured by A.Vogel (Bioforce AG), a Swiss company with a long history in herbal medicine. It is available as an oral solution that can be taken directly or diluted in a small amount of water.
The primary ingredient, Echinacea purpurea, is one of the most extensively studied medicinal plants worldwide. Native to North America, Echinacea has been used for centuries by Indigenous peoples for its immune-supporting properties. Modern research has confirmed that Echinacea purpurea extracts can modulate the innate immune system by stimulating the activity of macrophages (immune cells that engulf pathogens), increasing the production of cytokines (immune signaling molecules), and enhancing natural killer cell activity.
The second active component, elderberry (Sambucus nigra), adds complementary antiviral and antioxidant properties to the formulation. Elderberry is rich in anthocyanins and flavonoids, which have demonstrated the ability to inhibit viral replication in laboratory studies. Research published in the Journal of International Medical Research has shown that elderberry extract can reduce the duration and severity of influenza symptoms. The berries also contain vitamins A, B, and C, contributing additional nutritional support during illness.
Together, these two ingredients are designed to provide a synergistic effect: Echinacea activates the non-specific immune defense mechanisms while elderberry provides direct antiviral activity and reduces excessive inflammatory cytokine production. This combination approach targets respiratory infections from multiple angles, potentially offering more comprehensive relief than either ingredient alone.
Echinacea purpurea stimulates phagocytic activity (the ability of immune cells to engulf and destroy pathogens) and increases the production of TNF-alpha, interleukins, and interferons — key molecules in the immune response. Elderberry anthocyanins bind to viral surface proteins, inhibiting viral attachment to host cells and reducing viral replication. This dual mechanism supports the body's natural ability to fight respiratory infections.
Primary uses
- Common cold relief: Reducing the severity and duration of cold symptoms including sore throat, nasal congestion, and cough
- Influenza-like infections: Supporting recovery from flu-like symptoms including fever, body aches, and fatigue
- Preventive use: Some evidence supports short-term preventive use during cold and flu season to reduce the likelihood of catching a cold
- Early intervention: Most effective when taken at the very first signs of a cold or flu, ideally within the first 24–48 hours of symptom onset
What Should You Know Before Taking Echinaforce Comp?
Before taking Echinaforce Comp, it is important to check for contraindications including autoimmune diseases, allergy to Asteraceae plants, and progressive systemic diseases. Certain drug interactions and special precautions for pregnancy, breastfeeding, and children also apply.
While Echinaforce Comp is an over-the-counter herbal product, it is not suitable for everyone. Understanding who should avoid this product and what precautions to take is essential for safe use. The European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) has published detailed monographs on Echinacea purpurea that outline important safety considerations.
Contraindications
Echinaforce Comp should not be used by people with the following conditions:
- Autoimmune diseases: Including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Hashimoto's thyroiditis, and other autoimmune conditions. Because Echinacea stimulates the immune system, it may worsen autoimmune symptoms by further activating an already overactive immune response.
- Progressive systemic diseases: Including tuberculosis, leukemia, collagenoses, and HIV/AIDS. Immune stimulation in these conditions could be harmful.
- Allergy to Asteraceae (daisy family): People with known hypersensitivity to Echinacea, chamomile, ragweed, chrysanthemums, marigolds, or other plants in the Compositae/Asteraceae family should avoid this product due to cross-reactivity risk.
- Children under 1 year: Not recommended due to insufficient safety data. For children aged 1–12 years, medical advice should be sought before use.
If you have any autoimmune condition or are taking immunosuppressive medications, do not use Echinaforce Comp without first consulting your healthcare provider. Stimulating the immune system while on immunosuppressive therapy can have serious consequences and may interfere with your treatment.
Warnings and Precautions
Users should be aware of the following precautions when taking Echinaforce Comp:
- Duration of use: Do not use continuously for more than 10 days without medical advice. If symptoms worsen or persist after 10 days, consult a healthcare professional as this may indicate a more serious underlying infection.
- Allergic reactions: Rarely, Echinacea products can cause allergic reactions including skin rash, itching, swelling, and in very rare cases, anaphylaxis. Discontinue use immediately if any allergic symptoms occur.
- Atopic individuals: People with a history of atopic conditions (eczema, allergic rhinitis, asthma) may have an increased risk of allergic reactions to Echinacea preparations.
- Alcohol content: The oral solution may contain ethanol. This should be considered by patients with liver disease, alcoholism, epilepsy, or those taking medications that interact with alcohol. It should also be noted for pregnant or breastfeeding women.
- Surgery: Some practitioners recommend discontinuing Echinacea at least 2 weeks before scheduled surgery due to potential effects on immune function and wound healing.
Pregnancy and Breastfeeding
The safety of Echinaforce Comp during pregnancy and breastfeeding has not been fully established through large-scale clinical trials. However, available evidence provides some guidance:
Pregnancy: A prospective cohort study published in the Archives of Internal Medicine, which followed 206 women who used Echinacea during the first trimester, found no increase in major malformations compared to controls. However, the EMA HMPC recommends that use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. Consult your healthcare provider before use.
Breastfeeding: There is insufficient data on the excretion of Echinacea components into breast milk. The elderberry component has not been adequately studied in breastfeeding women. Until more data is available, the EMA advises caution and recommends consulting a healthcare provider before use during breastfeeding.
How Does Echinaforce Comp Interact with Other Drugs?
Echinaforce Comp may interact with immunosuppressant medications, certain drugs metabolized by liver enzymes (particularly CYP3A4 and CYP1A2), and other herbal products with immune-modulating effects. The most clinically significant interactions involve immunosuppressive drugs where Echinacea's immune-stimulating action may oppose the intended treatment effect.
Drug interactions with herbal products can be complex and are not always as well-documented as those between conventional medicines. However, several important potential interactions with Echinaforce Comp have been identified through pharmacological studies, case reports, and the known mechanisms of action of its active ingredients.
The primary concern relates to Echinacea's effect on the immune system. Because Echinacea stimulates immune function, it can theoretically counteract the effects of any medication designed to suppress or modulate the immune system. Additionally, Echinacea purpurea has been shown in some studies to affect the activity of cytochrome P450 enzymes, particularly CYP3A4, CYP1A2, and CYP2C9, which are responsible for metabolizing many commonly used drugs.
Major Interactions
| Drug / Drug Class | Interaction Type | Clinical Effect | Recommendation |
|---|---|---|---|
| Cyclosporine | Pharmacodynamic | Echinacea may reduce immunosuppressive efficacy, risking transplant rejection | Avoid combination |
| Tacrolimus | Pharmacodynamic | Opposing effects on immune function may reduce drug effectiveness | Avoid combination |
| Systemic corticosteroids (prednisolone, dexamethasone) | Pharmacodynamic | Immune stimulation may partially counteract immunosuppressive effect | Consult physician |
| Methotrexate | Pharmacodynamic + Hepatotoxic | May reduce efficacy of methotrexate immunosuppression; additive liver stress risk | Avoid combination |
| Biologics (adalimumab, infliximab, etanercept) | Pharmacodynamic | Opposing effects on immune pathways may reduce biologic drug efficacy | Avoid combination |
Minor Interactions
| Drug / Drug Class | Interaction Type | Clinical Effect | Recommendation |
|---|---|---|---|
| CYP3A4 substrates (midazolam, simvastatin) | Pharmacokinetic | Possible mild inhibition of CYP3A4, slightly increasing drug levels | Monitor; usually not clinically significant |
| CYP1A2 substrates (caffeine, theophylline) | Pharmacokinetic | Possible mild effect on CYP1A2 metabolism | Monitor if taking narrow therapeutic index drugs |
| Warfarin | Pharmacokinetic (CYP) | Theoretical risk of altered INR due to CYP enzyme effects | Monitor INR more frequently |
| Other immune-stimulating herbs (astragalus, cat's claw) | Pharmacodynamic (additive) | Additive immune stimulation; theoretical risk of immune overstimulation | Avoid combining multiple immune stimulants |
It is important to note that many of these interactions are based on theoretical pharmacological considerations and limited clinical data. The actual clinical significance may vary between individuals. Always inform your healthcare provider and pharmacist about all herbal products you are taking, including Echinaforce Comp, to allow proper assessment of potential interactions.
What Is the Correct Dosage of Echinaforce Comp?
The typical adult dosage of Echinaforce Comp oral solution is 3–5 mL taken three times daily for acute cold and flu symptoms. Dosage may vary by age group and indication. For best results, start treatment at the first sign of symptoms and continue for up to 10 days.
Proper dosing of Echinaforce Comp is important for achieving therapeutic benefit while minimizing the risk of adverse effects. The following dosage recommendations are based on the manufacturer's guidelines, EMA monograph data, and clinical trial protocols. Always follow the specific dosing instructions provided with your product, as formulation strength may vary by market.
Adults
Standard adult dosage (ages 12 and above)
- Acute treatment: 3–5 mL of oral solution, three times daily
- At onset of symptoms: Some protocols recommend a higher initial dose of 5 mL every 2–3 hours on the first day, then reducing to three times daily
- Preventive use: 3 mL three times daily during cold and flu season (consult a healthcare provider for duration)
- Maximum treatment duration: 10 days for acute symptoms without medical supervision
Take with a small amount of water. The solution can be taken with or without food. Shake the bottle well before each use.
Children
Pediatric dosage considerations
- Children under 1 year: Not recommended
- Children 1–6 years: Only under medical supervision. If approved by a healthcare provider, a typical dose may be 1–2 mL three times daily
- Children 6–12 years: 2–3 mL three times daily, preferably under medical guidance
- Adolescents 12+ years: Adult dosage applies
Note: The EMA HMPC does not generally recommend Echinacea-containing products for children under 12 years due to limited safety data. Always consult a pediatrician before administering herbal medicines to children.
Elderly
Dosage for older adults
No specific dose adjustment is generally required for elderly patients. However, older adults should be mindful of the following:
- Consider potential interactions with multiple medications commonly taken by older adults
- Monitor for allergic reactions, especially if using Echinacea for the first time
- Be aware of the alcohol content in the oral solution if taking medications that interact with ethanol
- Consult a healthcare provider if taking immunosuppressive medications for any condition
Missed Dose
If you miss a dose of Echinaforce Comp, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten one. Missing an occasional dose is unlikely to significantly affect the overall therapeutic benefit, but consistent dosing provides the best results.
Overdose
No cases of serious overdose with Echinaforce Comp have been reported in the medical literature. Echinacea preparations are generally considered to have a wide margin of safety. However, taking significantly more than the recommended dose may increase the risk of gastrointestinal side effects (nausea, stomach pain, diarrhea) and allergic reactions. If you suspect an overdose, contact your local poison control center or seek medical attention. In the event of severe allergic symptoms such as difficulty breathing, swelling of the face or throat, or widespread skin rash, seek emergency medical care immediately.
| Patient Group | Dosage | Frequency | Maximum Duration | ||
|---|---|---|---|---|---|
| Adults & adolescents (12+) | 3–5 mL | 3 times daily | 10 days (acute) | ||
| Children 6–12 years | 2–3 mL | 3 times daily | 10 days (with medical advice) | ||
| Children 1–6 years | 1–2 mL | 3 times daily | Under medical supervision only | ||
| Children under 1 year | Not recommended | ||||
| Elderly | 3–5 mL | 3 times daily | 10 days; monitor for interactions | ||
What Are the Side Effects of Echinaforce Comp?
Echinaforce Comp is generally well-tolerated, but side effects can occur. The most common side effects are gastrointestinal symptoms (nausea, abdominal pain) and allergic skin reactions (rash, itching). Serious allergic reactions including anaphylaxis are rare but have been reported with Echinacea products.
Like all medicinal products, including herbal medicines, Echinaforce Comp can cause side effects, although not everyone will experience them. The overall safety profile of Echinacea purpurea preparations is considered favorable based on clinical trials and post-marketing surveillance data. The addition of elderberry concentrate does not appear to significantly alter the side effect profile, as elderberry is also generally well-tolerated.
The frequency estimates below are based on a combination of clinical trial data, post-marketing surveillance, and the EMA HMPC assessment reports for Echinacea purpurea. The individual reported frequencies may vary because side effect reporting for herbal medicines is often less systematic than for conventional pharmaceuticals.
Common (may affect up to 1 in 10 people)
- Nausea or mild stomach discomfort
- Abdominal pain or bloating
- Diarrhea
- Unpleasant taste
Uncommon (may affect up to 1 in 100 people)
- Skin rash (urticaria, eczema-like)
- Itching (pruritus)
- Headache
- Dizziness
- Mild fever
Rare (may affect up to 1 in 1,000 people)
- Angioedema (swelling of face, lips, tongue, or throat)
- Bronchospasm or dyspnea (breathing difficulty)
- Anaphylaxis (severe whole-body allergic reaction)
- Stevens-Johnson syndrome (very rare, reported with Echinacea products)
- Exacerbation of asthma symptoms
Stop taking Echinaforce Comp and seek emergency medical help immediately if you experience: difficulty breathing or wheezing, swelling of the face, lips, tongue, or throat, severe skin rash with blistering, rapid heartbeat with dizziness, or signs of anaphylaxis (collapse, loss of consciousness). These are signs of a serious allergic reaction that requires urgent treatment.
People with a history of atopy (allergic tendencies such as eczema, hay fever, or asthma) may be at increased risk of experiencing allergic reactions to Echinacea. A 2006 study published in the Annals of Allergy, Asthma & Immunology reported that the majority of Echinacea-related allergic reactions occurred in individuals with atopic backgrounds. If you have a history of allergies, discuss the use of Echinaforce Comp with your healthcare provider before starting treatment.
Long-term safety data for continuous use beyond 10 days is limited. The EMA HMPC advises that prolonged use (beyond 8–10 weeks) should be avoided without medical supervision due to theoretical concerns about immune system overstimulation, although clinical evidence for harm from extended use is sparse. Some researchers have hypothesized that prolonged immune stimulation could potentially down-regulate immune function over time, but this has not been clearly demonstrated in human studies.
How Should You Store Echinaforce Comp?
Store Echinaforce Comp at room temperature (15–25°C / 59–77°F), away from direct sunlight and moisture. Keep the bottle tightly closed after opening. Do not use the product after the expiry date printed on the packaging.
Proper storage is essential to maintain the potency and safety of herbal medicinal products. Echinaforce Comp, as an oral solution, is particularly sensitive to environmental factors that can degrade the active phytochemical compounds. Following these storage guidelines ensures that you receive the full therapeutic benefit from each dose.
- Temperature: Store at room temperature between 15°C and 25°C (59°F to 77°F). Do not freeze the solution. Avoid storing near heat sources such as radiators, stoves, or in direct sunlight.
- Light protection: Keep the product in its original packaging to protect from light, as UV radiation can degrade the active polyphenolic compounds in both Echinacea and elderberry extracts.
- Moisture: Store in a dry place. Do not store in the bathroom or other humid areas.
- After opening: Once opened, use within the timeframe specified on the product label (typically 3–6 months). Keep the bottle tightly closed after each use to minimize oxidation and contamination.
- Child safety: Keep out of sight and reach of children. The solution may contain ethanol, which poses a risk if ingested in large amounts by a child.
- Expiry date: Do not use Echinaforce Comp after the expiry date stated on the bottle and outer carton. The expiry date refers to the last day of that month.
- Disposal: Do not pour unused medicine down the drain or toilet. Return unused or expired products to your pharmacy for safe disposal in accordance with local environmental regulations.
Natural sedimentation or slight color variation in the solution is normal and does not indicate deterioration of the product. Shake the bottle well before each use to ensure uniform distribution of the active components. If the solution develops an unusual odor, changes color dramatically, or shows signs of mold, discard it immediately and do not use.
What Does Echinaforce Comp Contain?
Echinaforce Comp contains two active ingredients: a standardized extract of Echinacea purpurea (herb and root) and a concentrate of elderberry (Sambucus nigra) fruit juice. Inactive ingredients include ethanol and water, which serve as solvents for the herbal extract.
Understanding the composition of Echinaforce Comp helps you make informed decisions about its use, particularly if you have known allergies or sensitivities to specific ingredients. The formulation is relatively simple, reflecting the product's nature as a herbal preparation.
Active ingredients
- Echinacea purpurea extract (herb and root): A standardized hydroethanolic extract prepared from freshly harvested Echinacea purpurea. This includes the aerial parts (stems, leaves, flowers) and roots of the plant, which contain the key bioactive compounds: alkamides, cichoric acid, polysaccharides, and glycoproteins. The extraction process is designed to preserve the full spectrum of active phytochemicals.
- Elderberry (Sambucus nigra) fruit concentrate: A concentrated preparation from the berries of the European elder tree. Rich in anthocyanins (particularly cyanidin-3-glucoside and cyanidin-3-sambubioside), flavonoids (quercetin, rutin), and vitamins. The concentration process preserves the key antiviral and antioxidant compounds.
Inactive ingredients (excipients)
- Ethanol (alcohol): Used as a solvent and preservative in the herbal extract. The ethanol content varies by market but is typically in the range of 55–65% v/v in the concentrated solution. Each dose contains a small amount of alcohol.
- Purified water: Used as part of the extraction solvent system.
Echinaforce Comp oral solution contains ethanol. Each recommended adult dose (3–5 mL) contains a small amount of alcohol. While this is generally not clinically significant for most adults, it should be considered by patients with liver disease, alcohol dependency, epilepsy, pregnant or breastfeeding women, and when giving the product to children. If the alcohol content is a concern, discuss alternatives with your healthcare provider or pharmacist.
The product does not contain added sugars, artificial sweeteners, artificial colors, or artificial flavors. It is free from gluten, lactose, and gelatin. The formulation is suitable for vegetarians and vegans. However, patients with specific dietary requirements or allergies should always check the product label for the most up-to-date ingredients list, as formulations may vary slightly between markets.
Frequently Asked Questions About Echinaforce Comp
Echinaforce Comp is a herbal medicinal product used for the relief and prevention of common cold and flu-like symptoms. It combines Echinacea purpurea extract with elderberry (Sambucus nigra) concentrate to support the immune system. It is most effective when started at the first signs of a cold — ideally within 24–48 hours of symptom onset — and can help reduce both the severity and duration of symptoms.
For acute cold and flu symptoms, Echinaforce Comp is typically used for up to 10 days. If your symptoms persist or worsen after this period, you should consult a healthcare professional. Some clinical evidence supports preventive use for up to 4 months during cold and flu season, but this should ideally be supervised by a healthcare provider. Continuous long-term use without breaks is not recommended.
There are no known major interactions between Echinaforce Comp and most common antibiotics. However, it is always best practice to inform your doctor or pharmacist about all products you are taking, including herbal remedies. If your doctor has prescribed antibiotics, it means they suspect a bacterial infection, and herbal immune support alone is not a substitute for antibiotic treatment. Follow your doctor's advice regarding antibiotic use.
Echinaforce Comp is not recommended for children under 1 year of age. For children aged 1–12 years, the EMA advises caution and recommends seeking medical advice before use due to limited safety data. Children over 12 years can generally use the adult dosage. The solution contains alcohol, which is an additional consideration for pediatric use. Always consult a pediatrician before giving herbal medicines to children.
If you are allergic to plants in the Asteraceae (daisy) family — which includes chamomile, ragweed, chrysanthemums, and marigolds — you should not take Echinaforce Comp due to potential cross-reactivity. People with atopic conditions (eczema, hay fever, asthma) may have a higher risk of allergic reactions to Echinacea and should discuss use with their healthcare provider first. If you develop any signs of an allergic reaction (rash, itching, swelling, difficulty breathing), stop taking the product immediately and seek medical attention.
All information is based on international medical guidelines and peer-reviewed research: EMA HMPC monographs on Echinacea purpurea (2021), Cochrane systematic review of Echinacea for preventing and treating the common cold (2014, updated), WHO monographs on selected medicinal plants, ESCOP monographs, and randomized controlled trials published in peer-reviewed journals. All medical claims are grounded in the highest available quality of evidence.
References
- European Medicines Agency (EMA). Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Echinacea purpurea (L.) Moench, herba recens. EMA/HMPC/48704/2018. 2021.
- Karsch-Völk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K. Echinacea for preventing and treating the common cold. Cochrane Database of Systematic Reviews. 2014;(2):CD000530. doi:10.1002/14651858.CD000530.pub3
- Hawkins J, Baker C, Cherry L, Dunne E. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials. Complementary Therapies in Medicine. 2019;42:361-365. doi:10.1016/j.ctim.2018.12.004
- Schapowal A, Klein P, Johnston SL. Echinacea reduces the risk of recurrent respiratory tract infections and complications: a meta-analysis of randomized controlled trials. Advances in Therapy. 2015;32(3):187-200. doi:10.1007/s12325-015-0194-4
- World Health Organization. WHO monographs on selected medicinal plants. Vol. 1. Geneva: World Health Organization; 1999. Radix Echinaceae.
- ESCOP Monographs. Echinaceae purpureae herba. European Scientific Cooperative on Phytotherapy. 2nd edition. 2003.
- Tiralongo E, Wee SS, Lea RA. Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial. Nutrients. 2016;8(4):182. doi:10.3390/nu8040182
- Goel V, Lovlin R, Barton R, et al. Efficacy of a standardized Echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Pharmacy and Therapeutics. 2004;29(1):75-83.
- Perri D, Dugoua JJ, Mills E, Koren G. Safety and efficacy of Echinacea (Echinacea angustifolia, E. purpurea and E. pallida) during pregnancy and lactation. Canadian Journal of Clinical Pharmacology. 2006;13(3):e262-e267.
- Mullins RJ, Heddle R. Adverse reactions associated with Echinacea: the Australian experience. Annals of Allergy, Asthma & Immunology. 2002;88(1):42-51.
About Our Medical Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, which includes licensed physicians, pharmacologists, and specialists in phytotherapy and evidence-based medicine. Our team follows international guidelines from the WHO, EMA, and ESCOP to ensure that all content meets the highest standards of medical accuracy.
Board-certified physicians with expertise in pharmacology, clinical medicine, and herbal therapeutics. All content reviewed according to GRADE evidence framework.
Independent medical content with no commercial funding or pharmaceutical sponsorship. Evidence Level 1A based on systematic reviews and meta-analyses of randomized controlled trials.